Group Outlook 2020
In 2020, we expect to increase Group sales1 by 3% to 6% in constant currency. Group net income2,3 is expected to develop in a range of -4% to +1%. Fresenius recognizes the increasing COVID-19 case numbers, and the associated various containment measures being enacted in many of the Company’s relevant markets. Thus, the Group’s FY/20 guidance assumes no containment measures that have a significant and direct impact on the health care sector that are not appropriately compensated.